Clinical Research & Reference Standard Compendium
TB-500 Spray - Scientific Literature
I. Abstract & Overview
TB-500 corresponds to thymosin beta-4, a 43-residue peptide that ranks among the most abundant intracellular proteins in many cell types. Its defining molecular property is actin sequestration: it binds monomeric G-actin and maintains an unpolymerized reserve, thereby setting the pool available for filament assembly. Malinda and colleagues reported in 1997 that it drives directional migration of human endothelial cells, establishing the migration phenotype that dominates the literature. Bock-Marquette and colleagues later described activation of integrin-linked kinase and Akt signaling, adding a survival pathway to the cytoskeletal one, while Badamchian and colleagues reported downregulation of inflammatory mediators. The peptide is intrinsically disordered in solution and folds only upon binding actin, which accounts for its unusual resistance to aggregation. Research Use Only (RUO).
II. Chemical Specifications
| Molecular Formula | C212H350N56O78S (full-length 43-residue thymosin beta-4) |
|---|---|
| Molar Mass | 4963 g/mol (PubChem CID 16132341, Timbetasin) — confirm whether the lot is full-length or the short active fragment with manufacturer COA |
| CAS Registry Number | 77591-33-4 |
| Amino Acid Sequence | Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser (43 residues; single methionine; no cysteine) |
III. Mechanism & Cellular Signaling Pathways
Thymosin beta-4 works through direct protein binding rather than receptor activation, which sets it apart from nearly every other peptide in recovery research. Its central actin-binding motif engages monomeric G-actin with modest affinity and holds it in a non-polymerizable state. Because filament assembly depends on the concentration of free monomer, this sequestration directly governs how quickly actin networks build and dissolve, and therefore how cells change shape and migrate. Research shows the effect is dose-dependent and measurable in cell-free polymerization assays, meaning it does not require any cellular machinery. Beyond the cytoskeleton, laboratory investigations describe activation of integrin-linked kinase and downstream Akt signaling, upregulation of laminin-5, and suppression of inflammatory mediator release. Unlike BPC-157, whose mechanism remains poorly defined, thymosin beta-4 has a specific, structurally characterized molecular partner.
IV. Primary Research Directions
- **Actin Sequestration Assays:** Research shows dose-dependent binding of monomeric G-actin, measurable directly in cell-free pyrene-actin polymerization assays without any cellular machinery.
- **Endothelial Cell Migration:** Malinda and colleagues (1997) report directional migration of human umbilical vein endothelial cells, quantified in scratch-wound and Boyden chamber formats.
- **Integrin-Linked Kinase Signaling:** Bock-Marquette and colleagues (2004) describe activation of integrin-linked kinase and downstream Akt, giving labs a survival pathway distinct from the cytoskeletal effect.
- **Inflammatory Mediator Studies:** Badamchian and colleagues (2003) report downregulation of inflammatory mediators, assessed by cytokine panel in endotoxin-challenged models.
- **Extracellular Matrix Remodeling:** Laboratory investigations describe upregulated laminin-5 expression, measurable by immunoblot in epithelial and endothelial monolayer systems.
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Malinda, K. M., Goldstein, A. L., & Kleinman, H. K. (1997). 'Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.' FASEB Journal, 11(6), 474-481. DOI: 10.1096/fasebj.11.6.9194528 | PMID: 9194528
- Bock-Marquette, I., Saxena, A., White, M. D., et al. (2004). 'Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.' Nature, 432(7016), 466-472. DOI: 10.1038/nature03000 | PMID: 15565145
- Badamchian, M., Fagarasan, M. O., Danner, R. L., et al. (2003). 'Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock.' International Immunopharmacology, 3(8), 1225-1233. DOI: 10.1016/S1567-5769(03)00024-9 | PMID: 12860178
TB-500 Spray
Abstract & Overview
TB-500 corresponds to thymosin beta-4, a 43-residue peptide that ranks among the most abundant intracellular proteins in many cell types. Its defining molecular property is actin sequestration: it binds monomeric G-actin and maintains an unpolymerized reserve, thereby setting the pool available for filament assembly. Malinda and colleagues reported in 1997 that it drives directional migration of human endothelial cells, establishing the migration phenotype that dominates the literature. Bock-Marquette and colleagues later described activation of integrin-linked kinase and Akt signaling, adding a survival pathway to the cytoskeletal one, while Badamchian and colleagues reported downregulation of inflammatory mediators. The peptide is intrinsically disordered in solution and folds only upon binding actin, which accounts for its unusual resistance to aggregation. Research Use Only (RUO).
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (TB-500 Spray) | 4.20 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 4.20 minutes represents the active compound (TB-500 Spray). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
Thymosin beta-4 works through direct protein binding rather than receptor activation, which sets it apart from nearly every other peptide in recovery research. Its central actin-binding motif engages monomeric G-actin with modest affinity and holds it in a non-polymerizable state. Because filament assembly depends on the concentration of free monomer, this sequestration directly governs how quickly actin networks build and dissolve, and therefore how cells change shape and migrate. Research shows the effect is dose-dependent and measurable in cell-free polymerization assays, meaning it does not require any cellular machinery. Beyond the cytoskeleton, laboratory investigations describe activation of integrin-linked kinase and downstream Akt signaling, upregulation of laminin-5, and suppression of inflammatory mediator release. Unlike BPC-157, whose mechanism remains poorly defined, thymosin beta-4 has a specific, structurally characterized molecular partner.
Primary Research Directions
**Actin Sequestration Assays:** Research shows dose-dependent binding of monomeric G-actin, measurable directly in cell-free pyrene-actin polymerization assays without any cellular machinery.
**Endothelial Cell Migration:** Malinda and colleagues (1997) report directional migration of human umbilical vein endothelial cells, quantified in scratch-wound and Boyden chamber formats.
**Integrin-Linked Kinase Signaling:** Bock-Marquette and colleagues (2004) describe activation of integrin-linked kinase and downstream Akt, giving labs a survival pathway distinct from the cytoskeletal effect.
**Inflammatory Mediator Studies:** Badamchian and colleagues (2003) report downregulation of inflammatory mediators, assessed by cytokine panel in endotoxin-challenged models.
**Extracellular Matrix Remodeling:** Laboratory investigations describe upregulated laminin-5 expression, measurable by immunoblot in epithelial and endothelial monolayer systems.
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Malinda, K. M., Goldstein, A. L., & Kleinman, H. K. (1997). 'Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.' FASEB Journal, 11(6), 474-481. DOI: 10.1096/fasebj.11.6.9194528 | PMID: 9194528
Bock-Marquette, I., Saxena, A., White, M. D., et al. (2004). 'Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.' Nature, 432(7016), 466-472. DOI: 10.1038/nature03000 | PMID: 15565145
Badamchian, M., Fagarasan, M. O., Danner, R. L., et al. (2003). 'Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock.' International Immunopharmacology, 3(8), 1225-1233. DOI: 10.1016/S1567-5769(03)00024-9 | PMID: 12860178
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
